Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors from the central anxious process, conolidine modulates alternate molecular targets. A Science Advancements research found that conolidine interacts Using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. By https://lorenzotelsn.glifeblog.com/36428557/the-ultimate-guide-to-alternative-natural-pain-relief-to-replace-traditional-painkillers